Michael M. Strage
Founder bei ANGIOGENEX, INC.
Profil
Michael M.
Strage is the founder.
In 1996, he founded Axonyx, Inc. where he held the title of Chief Administrative Officer & Vice President.
In 1999, he founded AngioGenex, Inc. where he holds the titles of Chief Operations Officer, Director & VP.
He also worked as an Associate at Hancock Rothert & Bunshoft LLP.
Aktive Positionen von Michael M. Strage
Unternehmen | Position | Beginn |
---|---|---|
ANGIOGENEX, INC. | Founder | 31.03.1999 |
Ehemalige bekannte Positionen von Michael M. Strage
Unternehmen | Position | Ende |
---|---|---|
Hancock Rothert & Bunshoft LLP
Hancock Rothert & Bunshoft LLP Miscellaneous Commercial ServicesCommercial Services Part of Duane Morris LLP, Hancock Rothert & Bunshoft LLP is a legal advisory services provider. The private company is based in Los Angeles, CA. Hancock Rothert & Bunshoft was acquired by Duane Morris LLP on January 01, 2006. | Corporate Officer/Principal | - |
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | Founder | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Axonyx, Inc.
Axonyx, Inc. Pharmaceuticals: MajorHealth Technology Axonyx, Inc. is an biopharmaceutical company, which manufactures medical products and technologies to treat Alzheimer's disease and other Central Nervous System disorders. It is located in New York, NY. | Health Technology |
Hancock Rothert & Bunshoft LLP
Hancock Rothert & Bunshoft LLP Miscellaneous Commercial ServicesCommercial Services Part of Duane Morris LLP, Hancock Rothert & Bunshoft LLP is a legal advisory services provider. The private company is based in Los Angeles, CA. Hancock Rothert & Bunshoft was acquired by Duane Morris LLP on January 01, 2006. | Commercial Services |
AngioGenex, Inc.
AngioGenex, Inc. Pharmaceuticals: MajorHealth Technology AngioGenex, Inc. operates as a biopharmaceutical company, which engages in developing and commercializing novel platform of anti-proliferative drugs for the treatment of cancer and macular degeneration. The company was founded by Michael M. Strage and Robert Benezra in March 1999 and is headquartered in New York, NY. | Health Technology |